The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats.
Saved in:
| Title: | The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats. |
|---|---|
| Authors: | Duttaroy A; Novartis Institutes for Biomedical Research, Inc., 100 Technology Square, Cambridge, MA 02139, USA., Voelker F, Merriam K, Zhang X, Ren X, Subramanian K, Hughes TE, Burkey BF |
| Source: | European journal of pharmacology [Eur J Pharmacol] 2011 Jan 15; Vol. 650 (2-3), pp. 703-7. Date of Electronic Publication: 2010 Nov 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
